Department of Clinical Pharmacy, UMass Memorial Medical Center, 55 Lake Avenue North, Worcester, MA, 01655, USA.
Department of Population and Quantitative Health Sciences, UMass Medical School, Worcester, MA, USA.
Neurocrit Care. 2020 Oct;33(2):533-541. doi: 10.1007/s12028-020-00928-0.
Hypernatremia has been associated with mortality in neurocritically ill patients, with and without traumatic brain injury (TBI). These studies, however, lack concomitant adjustment for hyperchloremia as a physiologically co-occurring finding despite the associations with hyperchloremia and worse outcomes after trauma, sepsis, and intracerebral hemorrhage. The objective of our study was to examine the association of concomitant hypernatremia and hyperchloremia with in-hospital mortality in moderate-severe TBI (msTBI) patients.
We retrospectively analyzed prospectively collected data from the OPTIMISM-study and included all msTBI patients consecutively enrolled between 11/2009 and 1/2017. Time-weighted average (TWA) sodium and chloride values were calculated for all patients to examine the unadjusted mortality rates associated with the burden of hypernatremia and hyperchloremia over the entire duration of the intensive care unit stay. Multivariable logistic regression modeling predicting in-hospital mortality adjusted for validated confounders of msTBI mortality was applied to evaluate the concomitant effects of hypernatremia and hyperchloremia. Internal bootstrap validation was performed.
Of the 458 patients included for analysis, 202 (44%) died during the index hospitalization. Fifty-five patients (12%) were excluded due to missing data. Unadjusted mortality rates were nearly linearly increasing for both TWA sodium and TWA chloride, and were highest for patients with a TWA sodium > 160 mmol/L (100% mortality) and TWA chloride > 125 mmol/L (94% mortality). When evaluated separately in the multivariable analysis, TWA sodium (per 10 mmol/L change: adjusted OR 4.0 [95% CI 2.1-7.5]) and TWA chloride (per 10 mmol/L change: adjusted OR 3.9 [95% CI 2.2-7.1]) independently predicted in-hospital mortality. When evaluated in combination, TWA chloride remained independently associated with in-hospital mortality (per 10 mmol/L change: adjusted OR 2.9 [95% CI 1.1-7.8]), while this association was no longer observed with TWA sodium values (per 10 mmol/L change: adjusted OR 1.5 [95% CI 0.51-4.4]).
When concomitantly adjusting for the burden of hyperchloremia and hypernatremia, only hyperchloremia was independently associated with in-hospital mortality in our msTBI cohort. Pending validation, our findings may provide the rationale for future studies with targeted interventions to reduce hyperchloremia and improve outcomes in msTBI patients.
高钠血症与神经危重症患者的死亡率相关,无论是否存在创伤性脑损伤(TBI)。然而,这些研究缺乏同时调整高氯血症的情况,尽管高氯血症与创伤后、脓毒症和脑出血后的不良结局相关。我们的研究目的是研究中度至重度 TBI(msTBI)患者中同时发生的高钠血症和高氯血症与院内死亡率的关系。
我们回顾性分析了 OPTIMISM 研究中前瞻性收集的数据,纳入了 2009 年 11 月至 2017 年 1 月期间连续入组的所有 msTBI 患者。计算所有患者的时间加权平均(TWA)钠和氯值,以检查整个 ICU 住院期间高钠血症和高氯血症负担与死亡率之间的关系。应用多变量逻辑回归模型预测 msTBI 死亡率的校正混杂因素,以评估高钠血症和高氯血症的同时作用。进行内部自举验证。
在纳入分析的 458 例患者中,202 例(44%)在住院期间死亡。由于数据缺失,55 例患者(12%)被排除在外。TWA 钠和 TWA 氯的未调整死亡率几乎呈线性增加,TWA 钠>160 mmol/L(100%死亡率)和 TWA 氯>125 mmol/L(94%死亡率)的患者死亡率最高。在多变量分析中分别评估时,TWA 钠(每变化 10 mmol/L:调整后的 OR 4.0[95%CI 2.1-7.5])和 TWA 氯(每变化 10 mmol/L:调整后的 OR 3.9[95%CI 2.2-7.1])独立预测院内死亡率。当同时评估时,TWA 氯与院内死亡率独立相关(每变化 10 mmol/L:调整后的 OR 2.9[95%CI 1.1-7.8]),而 TWA 钠值的相关性不再观察到(每变化 10 mmol/L:调整后的 OR 1.5[95%CI 0.51-4.4])。
在同时调整高氯血症和高钠血症的负担时,只有高氯血症与我们的 msTBI 队列中的院内死亡率独立相关。在进一步验证之前,我们的研究结果可能为未来的研究提供依据,这些研究旨在通过靶向干预来降低高氯血症并改善 msTBI 患者的结局。